CORC

浏览/检索结果: 共7条,第1-7条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer The ALTER 0303 Phase 3 Randomized Clinical Trial 期刊论文
2018, 卷号: 4, 期号: 11, 页码: 1569-1575
作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03
China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version) 期刊论文
2017, 卷号: 13, 期号: 1, 页码: 87-103
作者:  Shi, Yuankai;  Sun, Yan;  Yu, Jinming;  Ding, Cuimin;  Wang, Ziping
收藏  |  浏览/下载:10/0  |  提交时间:2020/01/04
Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer 期刊论文
2016, 卷号: 16, 页码: 265
作者:  Sun, Yan;  Cheng, Ying;  Hao, Xuezhi;  Wang, Jie;  Hu, Chengping
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/04
中国埃克替尼治疗非小细胞肺癌专家共识(2015版) 期刊论文
2015, 卷号: 7, 期号: 7, 页码: 397-400
作者:  Shi Yuankai;  Sun Yan;  Ding Cuimin;  Wang Ziping;  Wang Changli
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/04
A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC) 期刊论文
2014, 卷号: 86, 期号: 2, 页码: 207-212
作者:  Hu, Xingsheng;  Han, Baohui;  Gu, Aiqin;  Zhang, Yiping;  Jiao, Shun Chang
收藏  |  浏览/下载:13/0  |  提交时间:2020/01/13
Genome-Wide Association Study Identifies a Novel Susceptibility Locus at 12q23.1 for Lung Squamous Cell Carcinoma in Han Chinese 期刊论文
2013, 卷号: 9, 期号: 1
作者:  Dong, Jing;  Jin, Guangfu;  Wu, Chen;  Guo, Huan;  Zhou, Baosen
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/13
Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population 期刊论文
2012, 卷号: 44, 期号: 8, 页码: 895-+
作者:  Dong, Jing;  Hu, Zhibin;  Wu, Chen;  Guo, Huan;  Zhou, Baosen
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/13


©版权所有 ©2017 CSpace - Powered by CSpace